In vivo, in vitro, in silico...

Critical Care Medicine

Volumn 32, Issue 10, 2004, Pages 2159-2160

  Buchman, Timothy G ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CD11B ANTIGEN; CD18 ANTIGEN; INTERLEUKIN 1; L SELECTIN; RECEPTOR; TUMOR NECROSIS FACTOR;

CLINICAL TRIAL; EDITORIAL; HUMAN; INFLAMMATION; INTENSIVE CARE; MATHEMATICAL MODEL; MICROVASCULATURE; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; SEPSIS;

ANTI-INFLAMMATORY AGENTS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; MODELS, THEORETICAL; SEPSIS;

EID: 5644258227     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000142900.95726.7F     Document Type: Editorial

References (2)

1. An G: In silico experiments of existing and hypothetical cytokine-directed clinical trials using agent-based modeling. Crit Care Med 2004; 32:2050-2060
2. Clermont G, Bartels J, Kumar R, et al: In silico design of clinical trials: A method coming of age. Crit Care Med 2004; 32:0000-0000